US Stock MarketDetailed Quotes
GNPX Genprex Watchlist
1.040 +0.106+11.35% Close 06/02 16:00 ET
0.970-0.070-6.73% Pre 05:07 ET
0.990Open0.934Pre Close1.65MTurnover3.18%Turnover RatioLossP/E (TTM)54.06MMarket Cap2.67052wk HighLossP/E (Static)51.98MShares0.72352wk Low2.92P/B53.23MFloat Cap19.450Historical High--Dividend TTM51.18MShs Float0.231Historical Low--Div YieldTTM8.56%Amplitude1.013Avg Price1Lot Size
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.